Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreNext stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreNearly a dozen financial institutions agreed to pay more than $1.8 billion collectively for failing…
Read MoreIntel Corp. disagrees with Nvidia Corp. when it comes to Moore’s Law as Intel Chief…
Read MoreThe numbers: U.S. new home sales surged 28.8% to a seasonally-adjusted annual rate of 685,000…
Read MoreThe successful collision of a NASA spacecraft with an asteroid lifted space sector stocks before…
Read MoreThe successful collision of a NASA spacecraft with an asteroid lifted space sector stocks before…
Read MoreRussia might use nuclear weapons to achieve its goals in the war in Ukraine—a risk…
Read MoreThe numbers: Orders at U.S. factories for long-lasting goods fell 0.2% in August mainly because…
Read MoreThe numbers: Orders at U.S. factories for long-lasting goods fell 0.2% in August mainly because…
Read More
22 dividend stocks screened for quality and safety
Now that the S&P 500 has hit a new closing low for 2022, it is…
Read More